Today

Agents

Chat

Arena

Discover

More

App

Veracyte, Inc.: Piper Sandler cuts target price to $30 from $54

VCYT•2026-11-10

Piper Sandler cut its target price for Veracyte to $30 from $54.

Related News

H

Hims & Hers to offer unapproved peptides after US eases curbs

HIMS•2026-11-10

Coeur Mining expects 2026 free cash flow to double to over $1.3 billion

CDE•2026-11-10

CEVA, Inc.: JP Morgan cuts target price to $35 from $45

CEVA•2026-11-10

Oil falls as Trump downplays prospect of escalation with Iran

USO•2026-11-10

Immunome, Inc.: Piper Sandler cuts target price to $30 from $33

IMNM•2026-11-10

Veracyte, Inc.: Piper Sandler cuts target price to $30 from $54 - VCYT News | Rallies